[go: up one dir, main page]

MX2013014428A - Composiciones nutricionales que tienen componentes exogenos de membrana de globulos de grasa de leche. - Google Patents

Composiciones nutricionales que tienen componentes exogenos de membrana de globulos de grasa de leche.

Info

Publication number
MX2013014428A
MX2013014428A MX2013014428A MX2013014428A MX2013014428A MX 2013014428 A MX2013014428 A MX 2013014428A MX 2013014428 A MX2013014428 A MX 2013014428A MX 2013014428 A MX2013014428 A MX 2013014428A MX 2013014428 A MX2013014428 A MX 2013014428A
Authority
MX
Mexico
Prior art keywords
nutritional compositions
milk fat
fat globule
globule membrane
membrane components
Prior art date
Application number
MX2013014428A
Other languages
English (en)
Inventor
Doug Bolter
Zamzam Fariba Roughead
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2013014428A publication Critical patent/MX2013014428A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
    • A23C9/1512—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C21/00—Whey; Whey preparations
    • A23C21/06—Mixtures of whey with milk products or milk components
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
    • A23C9/1516—Enrichment or recombination of milk (excepted whey) with milk fat, cream of butter without using isolated or concentrated milk proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)

Abstract

Se proporcionan composiciones nutricionales que incluyen componentes de la membrana del glóbulo de grasa de la leche ("MFGM", por sus siglas en inglés) y al menos un nutriente. Los lípidos activos derivados de la leche, ayudan a modular las condiciones que por lo general se encuentran en los ancianos que incluyen, por ejemplo, inflamación de bajo grado, pérdida de la masa corporal magra, inestabilidad de la membrana celular del músculo esquelético, e inflamación articular. Los nutrientes pueden incluir, pero no se limitan a, micelas de proteína de suero de leche, citrulina, ácidos grasos de cadena ramificada, y ácido a-hidroxicaproico ("a-HICA"). También se proporcionan métodos para tratar a un individuo que tiene, o en riesgo de tener, una afección médica.
MX2013014428A 2011-06-08 2011-06-08 Composiciones nutricionales que tienen componentes exogenos de membrana de globulos de grasa de leche. MX2013014428A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/039612 WO2012170021A1 (en) 2011-06-08 2011-06-08 Nutritional compositions having exogenous milk fat globule membrane components

Publications (1)

Publication Number Publication Date
MX2013014428A true MX2013014428A (es) 2014-03-31

Family

ID=44627130

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013014428A MX2013014428A (es) 2011-06-08 2011-06-08 Composiciones nutricionales que tienen componentes exogenos de membrana de globulos de grasa de leche.

Country Status (13)

Country Link
US (1) US20140105875A1 (es)
EP (1) EP2717705A1 (es)
JP (1) JP2014516565A (es)
CN (1) CN103596440A (es)
AU (1) AU2011370626A1 (es)
BR (1) BR112013031086A2 (es)
CA (1) CA2836241A1 (es)
MX (1) MX2013014428A (es)
PH (1) PH12013502290A1 (es)
RU (1) RU2013158289A (es)
SG (1) SG194918A1 (es)
WO (1) WO2012170021A1 (es)
ZA (1) ZA201400116B (es)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9662358B2 (en) * 2011-10-18 2017-05-30 Nestec S.A. Composition for use in the promotion of healthy bone growth and/or in the treatment of bone disease
BR112014007829A2 (pt) * 2011-10-18 2017-04-18 Nestec Sa composição para uso na promoção de absorção de magnésio e/ou retenção de magnésio
PH12014500443A1 (en) * 2011-10-18 2014-04-14 Socia‰Ta‰ Des Produits Nestla‰ S A Composition for use in brain growth and/or cognitive and/or psychomotor development
ES2550321T3 (es) * 2011-10-21 2015-11-06 Nestec S.A. Micelas de proteína de suero para aumentar la masa muscular y el rendimiento
JP2014172861A (ja) * 2013-03-08 2014-09-22 Snow Brand Milk Products Co Ltd 抗炎症剤
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
CN108271917A (zh) 2013-03-08 2018-07-13 艾斯姆食品公司 大米蛋白补充剂
JP6158565B2 (ja) * 2013-04-09 2017-07-05 花王株式会社 筋タンパク質合成シグナル増強剤
SE537951C2 (sv) * 2013-07-01 2015-12-01 Hero Ag Profylaktisk användning av modersmjölksersättning mot otit
US9241923B2 (en) * 2013-07-16 2016-01-26 Mead Johnson Nutrition Company Methods for promoting neuronal development and/or health
EP3021942A4 (en) * 2013-07-19 2017-04-19 The Regents of The University of California Milk fat globule epidermal growth factor 8 regulates fatty acid uptake
US10709770B2 (en) * 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
JP6279714B2 (ja) * 2014-03-25 2018-02-14 株式会社ヤクルト本社 睡眠の質改善剤
JP6446265B2 (ja) * 2014-12-26 2018-12-26 花王株式会社 固形状組成物
US10525016B2 (en) * 2015-06-03 2020-01-07 Mead Johnson Nutrition Company Nutritional compositions containing an elevated level of inositol and uses thereof
CA3000841A1 (en) * 2015-10-02 2017-04-06 Glanbia Nutritionals (Ireland) Ltd. Protein hydrolysate, method for making, and use
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
WO2017075289A1 (en) 2015-10-27 2017-05-04 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
ES2946185T3 (es) * 2015-12-25 2023-07-13 Otsuka Pharma Co Ltd Composición alimenticia similar a un gel
JP7260951B2 (ja) * 2016-07-26 2023-04-19 花王株式会社 膝の痛み改善剤
JP7397562B2 (ja) * 2016-07-26 2023-12-13 花王株式会社 腰痛改善剤
JP7260952B2 (ja) * 2016-07-26 2023-04-19 花王株式会社 肩の痛み改善剤
JP7260950B2 (ja) * 2016-07-26 2023-04-19 花王株式会社 腰痛改善剤
JP6774675B2 (ja) * 2016-08-23 2020-10-28 花王株式会社 固形状組成物
JP6849390B2 (ja) * 2016-10-28 2021-03-24 花王株式会社 関節のこわばり改善剤
EP3601620A1 (en) 2017-03-27 2020-02-05 Biogaia Ab Lactic acid bacteria, methods and uses thereof
CN107156302A (zh) * 2017-04-17 2017-09-15 南昌大学 一种含乳脂肪球膜的婴幼儿配方奶粉及制备方法
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法
CN111343992A (zh) * 2017-11-08 2020-06-26 雀巢产品有限公司 橄榄苦苷的生物转化
AU2018365217B2 (en) * 2017-11-08 2024-02-15 Société des Produits Nestlé S.A. Homovanillyl alcohol (HVA), HVA isomer, methods of making compositions comprising such compounds, and methods using such compounds
JP6987613B2 (ja) * 2017-11-17 2022-01-05 花王株式会社 固形状組成物
CN108558991B (zh) * 2018-06-29 2020-06-09 上海铂辉生物科技有限公司 一种生物活性多肽giqdpkep及其制备方法和应用
US20220119489A1 (en) * 2019-01-25 2022-04-21 Children's Medical Center Corporation Compositions and methods for treating muscular dystrophy and related disorders
EP3941451A4 (en) * 2019-03-21 2022-12-14 Fonterra Co-Operative Group Limited Compositions comprising polar lipids for maintaining or increasing mobility and vitality
PH12022551086A1 (en) * 2019-11-08 2024-06-24 Abbott Lab Bovine milk-isolated powdered exosomes, nutritional compositions and methods
KR20210069460A (ko) * 2019-12-03 2021-06-11 솔루스첨단소재 주식회사 유청 유래 극성지질 농축 분획 조성물 및 이의 용도
GB2591983A (en) * 2019-12-04 2021-08-18 Mjn Us Holdings Llc Compositions and methods for preserving probiotic viability
JP2021171059A (ja) * 2020-04-21 2021-11-01 サンスター株式会社 遂行機能改善用組成物
CN112042750B (zh) * 2020-09-09 2022-04-05 北京三元食品股份有限公司 一种富含乳脂肪球膜蛋白、磷脂和低聚糖的婴幼儿配方奶粉及其制备方法
FI129515B (en) * 2020-11-06 2022-03-31 Salarusta Oy FOR USE IN THE PREVENTION AND / OR TREATMENT OF A DISEASE OR CONDITION RELATED TO THE DEGRADATION AND / OR DISTURBANCE OF THE DEGREE OF MONTOOSASE AND / OR INTEGRITY
DE102020133860A1 (de) * 2020-12-16 2022-06-23 MNT Systeme GmbH VERWENDUNG VON β-GALAKTOOLIGOSACCHRIDEN FÜR DIE HERSTELLUNG EINER KOSMETISCHEN UND/ODER PHARMAKOLOGISCH WIRKSAMEN ZUSAMMENSETZUNG
KR20230119213A (ko) * 2020-12-17 2023-08-16 신발란스 에스알엘 프로바이오틱 조성물 및 스트레스-관련 병태의 예방및/또는 치료에서 이의 용도
JP2024502024A (ja) * 2020-12-31 2024-01-17 アボット・ラボラトリーズ ウシ乳汁由来エクソソームを投与することによって関節の健康状態を向上させる方法
CN117042761A (zh) * 2021-03-26 2023-11-10 首尔大学校产学协力团 用于增强乳酸菌的生理功效的组合物
EP4094591A1 (en) * 2021-05-28 2022-11-30 Fonterra Co-Operative Group Limited Food supplement
CN114128757B (zh) * 2021-11-30 2023-08-04 内蒙古伊利实业集团股份有限公司 乳脂肪球膜在减少乳制品异味中的应用
CN114794491A (zh) * 2022-05-13 2022-07-29 北京名投营养科技有限公司 一种改善脑功能的组合物及其制备方法
WO2024089179A1 (en) * 2022-10-28 2024-05-02 Frieslandcampina Nederland B.V. Dairy lipid for lowering the glycoprotein acetyls (glyca)
CN115997937B (zh) * 2022-12-13 2024-03-12 黑龙江飞鹤乳业有限公司 含有乳脂肪球膜的营养组合物、用途及食品
NL2034054B1 (en) * 2023-01-30 2024-08-16 Efnatics B V Composition and method of preparation of bioactive triterpenoid milk fat globule formulations
FI131520B1 (en) * 2023-05-12 2025-06-06 Valio Ltd DAIRY PRODUCT AND METHOD FOR PRODUCING IT
WO2024243008A1 (en) * 2023-05-19 2024-11-28 Ohio State Innovation Foundation Compositions and methods of making and use thereof
CN116904378B (zh) * 2023-09-14 2023-12-29 山东中科嘉亿生物工程有限公司 促进骨成长的约氏乳杆菌jylo-010及菌剂、应用
CN118633748A (zh) * 2024-05-29 2024-09-13 哈尔滨工业大学 一种包含乳源mfg-e8的产品及其在改善衰老、学习和/或记忆障碍中的应用
CN119023859B (zh) * 2024-10-28 2025-01-21 中国检验认证集团湖南有限公司 一种食品原料粉中乳脂球膜蛋白的测定方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322589B1 (fr) 1987-12-23 1993-01-20 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
EP0880902A1 (fr) 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
ES2373400T3 (es) * 2006-03-27 2012-02-03 Nestec S.A. Micelas de proteína láctea.
EP1880612A1 (fr) * 2006-07-17 2008-01-23 Corman S.A. Ingrédient laitier enrichi en lipides polaires et applications de celui-ci
FR2908605A1 (fr) * 2006-11-21 2008-05-23 Groupe Lactalis Utilisation d'un ingredient contenant un concentre de membranes de globules gras du lait,pour la fabrication d'un aliment,d'une boisson ou d'un supplement alimentaire destine a une indication impliquant la paroi intestinale
WO2008124648A1 (en) * 2007-04-05 2008-10-16 Kelly Cox Butter related food product and method
CN101589757A (zh) * 2008-05-28 2009-12-02 北京健健康康生物技术有限公司 一种瓜氨酸冰淇淋及其制备方法
CA2768471A1 (en) * 2009-07-20 2011-01-27 Nestec S.A. Methods of attenuating the loss of functional status
PH12012501050A1 (en) * 2009-12-08 2013-02-04 Nestec Sa Infant formula with probiotics and milk fat globule membrane components

Also Published As

Publication number Publication date
AU2011370626A1 (en) 2013-11-28
CA2836241A1 (en) 2012-12-13
BR112013031086A2 (pt) 2016-11-29
CN103596440A (zh) 2014-02-19
EP2717705A1 (en) 2014-04-16
PH12013502290A1 (en) 2019-03-22
RU2013158289A (ru) 2015-07-20
ZA201400116B (en) 2017-09-27
JP2014516565A (ja) 2014-07-17
SG194918A1 (en) 2013-12-30
US20140105875A1 (en) 2014-04-17
WO2012170021A1 (en) 2012-12-13

Similar Documents

Publication Publication Date Title
MX2013014428A (es) Composiciones nutricionales que tienen componentes exogenos de membrana de globulos de grasa de leche.
PE20151882A1 (es) Composiciones nutricionales que contienen globulos grasos estructurados y usos de los mismos
EA201071246A1 (ru) Детское питание на основе жиров молочного происхождения
MX2013012228A (es) Composiciones nutricionales que tienen a-hica y metodos para utilizar las mismas.
RU2015136675A (ru) Содержащие обогащенную липидную фракцию питательные композиции и их применение
AR061896A1 (es) Ingrediente lacteo rico en componentes de la membrana de globulos grasos de la leche procedimiento de obtencion y aplicaciones del mismo
MX2013012522A (es) Sustituto de crema y metodos para hacer los mismos.
AR087003A1 (es) Dispositivo separador modular para el tratamiento de infecciones de la protesis de miembros humanos
AR056761A1 (es) UN CONCENTRADO DERIVADO DE UN PRODUCTO LÁCTEO ENRIQUECIDO CON SALILLACTOSA NATURAL Y UN PROCEDIMIENTO PARA LA PREPARACIoN DEL MISMO
MX2016012694A (es) Composiciones nutritivas dirigidas a sujetos que tienen alergias a proteinas de la leche de vaca.
PH12014500790A1 (en) Infant formula with high sn-2 palmitate and oligofructose
SG193246A1 (en) Nutritional compositions for increasing arginine levels and methods of using same
PH12013500556A1 (en) Staged infant feeding regimen to promote healthy development and growth
PH12019501025A1 (en) Natural compositions providing dietary management of colic
PH12018500035A1 (en) Nutritional compositions and methods for promoting cognitive development
MX2013009007A (es) Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas.
CO7310519A2 (es) Enriquecedor para un sucedáneo de la leche materna
MX388724B (es) Composicion nutricional pediatrica con peptidos lacteos para un crecimiento y desarrollo saludable.
MX380334B (es) Cepas de lactococcus lactis y preparaciones bacterianas de las mismas, para la produccion de peptidos bioactivos que tienen efectos antihipertensivos y de disminucion de colesterol en mamiferos; productos nutricionales y terapéuticos producidos a partir de los mismos.
AR098685A1 (es) Composiciones alimentarias saludables que presentan texturas de gel o espuma y que comprenden ovoproductos hidrolizados
Phillips Determining the protein needs of “older” persons one meal at a time
MX2024004278A (es) Productos y metodos para extender la vida util de productos sensibles al agua.
UY39909A (es) Composiciones de lactoferrina y métodos de uso
JP2019071792A (ja) 高たんぱくカレールゥ
CL2019001675A1 (es) Composiciones, formulaciones y procedimientos de obtención de una mezcla entre proteína de suero de leche, caseinato de calcio, fructooligosacáridos, vitamina d, inulina y vitamina c, que contribuye en la nutrición diaria, otorgando fuerza musculara y vitalidad.